CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis

Abstract Multiple Sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS), with a largely unknown etiology, where mitochondrial dysfunction likely contributes to neuroaxonal loss and brain atrophy. Mirroring the CNS, peripheral immune cells from patients with...

Full description

Bibliographic Details
Main Authors: Filipe Cortes-Figueiredo, Susanna Asseyer, Claudia Chien, Hanna G. Zimmermann, Klemens Ruprecht, Tanja Schmitz-Hübsch, Judith Bellmann-Strobl, Friedemann Paul, Vanessa A. Morais
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-57592-z
_version_ 1827301127870218240
author Filipe Cortes-Figueiredo
Susanna Asseyer
Claudia Chien
Hanna G. Zimmermann
Klemens Ruprecht
Tanja Schmitz-Hübsch
Judith Bellmann-Strobl
Friedemann Paul
Vanessa A. Morais
author_facet Filipe Cortes-Figueiredo
Susanna Asseyer
Claudia Chien
Hanna G. Zimmermann
Klemens Ruprecht
Tanja Schmitz-Hübsch
Judith Bellmann-Strobl
Friedemann Paul
Vanessa A. Morais
author_sort Filipe Cortes-Figueiredo
collection DOAJ
description Abstract Multiple Sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS), with a largely unknown etiology, where mitochondrial dysfunction likely contributes to neuroaxonal loss and brain atrophy. Mirroring the CNS, peripheral immune cells from patients with MS, particularly CD4+ T cells, show inappropriate mitochondrial phenotypes and/or oxidative phosphorylation (OxPhos) insufficiency, with a still unknown contribution of mitochondrial DNA (mtDNA). We hypothesized that mitochondrial genotype in CD4+ T cells might influence MS disease activity and progression. Thus, we performed a retrospective cross-sectional and longitudinal study on patients with a recent diagnosis of either Clinically Isolated Syndrome (CIS) or Relapsing–Remitting MS (RRMS) at two timepoints: 6 months (VIS1) and 36 months (VIS2) after disease onset. Our primary outcomes were the differences in mtDNA extracted from CD4+ T cells between: (I) patients with CIS/RRMS (PwMS) at VIS1 and age- and sex-matched healthy controls (HC), in the cross-sectional analysis, and (II) different diagnostic evolutions in PwMS from VIS1 to VIS2, in the longitudinal analysis. We successfully performed mtDNA whole genome sequencing (mean coverage: 2055.77 reads/base pair) in 183 samples (61 triplets). Nonetheless, mitochondrial genotype was not associated with a diagnosis of CIS/RRMS, nor with longitudinal diagnostic evolution.
first_indexed 2024-04-24T16:17:48Z
format Article
id doaj.art-979abfe0374e42a29c8da6d3ae53c51e
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T16:17:48Z
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-979abfe0374e42a29c8da6d3ae53c51e2024-03-31T11:21:04ZengNature PortfolioScientific Reports2045-23222024-03-0114111310.1038/s41598-024-57592-zCD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysisFilipe Cortes-Figueiredo0Susanna Asseyer1Claudia Chien2Hanna G. Zimmermann3Klemens Ruprecht4Tanja Schmitz-Hübsch5Judith Bellmann-Strobl6Friedemann Paul7Vanessa A. Morais8Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de LisboaExperimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité – Universitätsmedizin BerlinExperimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité – Universitätsmedizin BerlinExperimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité – Universitätsmedizin BerlinDepartment of Neurology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of HealthExperimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité – Universitätsmedizin BerlinExperimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité – Universitätsmedizin BerlinExperimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité – Universitätsmedizin BerlinInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de LisboaAbstract Multiple Sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS), with a largely unknown etiology, where mitochondrial dysfunction likely contributes to neuroaxonal loss and brain atrophy. Mirroring the CNS, peripheral immune cells from patients with MS, particularly CD4+ T cells, show inappropriate mitochondrial phenotypes and/or oxidative phosphorylation (OxPhos) insufficiency, with a still unknown contribution of mitochondrial DNA (mtDNA). We hypothesized that mitochondrial genotype in CD4+ T cells might influence MS disease activity and progression. Thus, we performed a retrospective cross-sectional and longitudinal study on patients with a recent diagnosis of either Clinically Isolated Syndrome (CIS) or Relapsing–Remitting MS (RRMS) at two timepoints: 6 months (VIS1) and 36 months (VIS2) after disease onset. Our primary outcomes were the differences in mtDNA extracted from CD4+ T cells between: (I) patients with CIS/RRMS (PwMS) at VIS1 and age- and sex-matched healthy controls (HC), in the cross-sectional analysis, and (II) different diagnostic evolutions in PwMS from VIS1 to VIS2, in the longitudinal analysis. We successfully performed mtDNA whole genome sequencing (mean coverage: 2055.77 reads/base pair) in 183 samples (61 triplets). Nonetheless, mitochondrial genotype was not associated with a diagnosis of CIS/RRMS, nor with longitudinal diagnostic evolution.https://doi.org/10.1038/s41598-024-57592-z
spellingShingle Filipe Cortes-Figueiredo
Susanna Asseyer
Claudia Chien
Hanna G. Zimmermann
Klemens Ruprecht
Tanja Schmitz-Hübsch
Judith Bellmann-Strobl
Friedemann Paul
Vanessa A. Morais
CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
Scientific Reports
title CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
title_full CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
title_fullStr CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
title_full_unstemmed CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
title_short CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
title_sort cd4 t cell mitochondrial genotype in multiple sclerosis a cross sectional and longitudinal analysis
url https://doi.org/10.1038/s41598-024-57592-z
work_keys_str_mv AT filipecortesfigueiredo cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT susannaasseyer cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT claudiachien cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT hannagzimmermann cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT klemensruprecht cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT tanjaschmitzhubsch cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT judithbellmannstrobl cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT friedemannpaul cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis
AT vanessaamorais cd4tcellmitochondrialgenotypeinmultiplesclerosisacrosssectionalandlongitudinalanalysis